ICD-10 Code for Long-term
The ICD-10-CM 2027 alphabetic index lists long-term with the subterms below. More specific codes depend on the details documented, as listed in the official index (32 codes, 32 billable).
Index entries for Long-term
- 5-fluorouracil –
Z79.631 - 6-mercaptopurine –
Z79.631 - adalimumab –
Z79.620 - agents affecting estrogen receptors and estrogen levels NEC –
Z79.818 - alkylating agent –
Z79.630 - anastrozole (Arimidex) –
Z79.811 - antibiotics –
Z79.2- short-term use - omit code
- anticoagulants –
Z79.01 - antidiabetic drugs, injectable, non-insulin –
Z79.85 - anti-inflammatory, non-steroidal (NSAID) –
Z79.1 - antimetabolite agent –
Z79.631 - antiplatelet –
Z79.02 - antithrombotics –
Z79.02 - antitumor antibiotic –
Z79.632 - apremilast –
Z79.61 - aromatase inhibitors –
Z79.811 - aspirin –
Z79.82 - azathioprine –
Z79.624 - birth control pill or patch –
Z79.3 - bisphosphonates –
Z79.83 - bleomycin –
Z79.632 - calcineurin inhibitor –
Z79.621 - chlorambucil –
Z79.630 - cisplatin –
Z79.630 - contraceptive, oral –
Z79.3 - cyclophosphamide –
Z79.630 - cyclosporine –
Z79.621 - cytarabine –
Z79.631 - doxorubicin –
Z79.632 - drug, specified NEC –
Z79.899 - estrogen receptor downregulators –
Z79.818 - etanercept –
Z79.620 - etoposide –
Z79.634 - Evista –
Z79.810 - exemestane (Aromasin) –
Z79.811 - Fareston –
Z79.810 - fulvestrant (Faslodex) –
Z79.818 - gonadotropin-releasing hormone (GnRH) –
Z79.818 - goserelin acetate (Zoladex) –
Z79.818 - hormone replacement –
Z79.890 - hydroxyurea –
Z79.64 - immunomodulators, unspecified –
Z79.60- specified NEC –
Z79.69
- specified NEC –
- immunomodulatory imide drug –
Z79.61 - immunosuppressants, unspecified –
Z79.60- specified NEC –
Z79.69
- specified NEC –
- immunosuppressive biologic –
Z79.620 - infliximab –
Z79.620 - inhibitors of nucleotide synthesis –
Z79.624 - insulin –
Z79.4 - irinotecan –
Z79.634 - Janus kinase inhibitor –
Z79.622 - lenalidomide –
Z79.61 - letrozole (Femara) –
Z79.811 - leuprolide acetate (leuprorelin) (Lupron) –
Z79.818 - mammalian target of rapamycin (mTOR) –
Z79.623 - megestrol acetate (Megace) –
Z79.818 - methadone for pain management –
Z79.891 - mitomycin C –
Z79.632 - mitotic inhibitor –
Z79.633 - monoclonal antibodies –
Z79.620 - mycophenolate –
Z79.624 - myelosuppressive agent –
Z79.64 - Nolvadex –
Z79.810 - non-insulin antidiabetic drug, injectable –
Z79.85 - non-steroidal anti-inflammatories (NSAID) –
Z79.1 - opiate analgesic –
Z79.891 - oral
- paclitaxel –
Z79.633 - plant alkaloids –
Z79.633 - pomalidomide –
Z79.61 - purine synthesis (IMDH) –
Z79.624 - raloxifene (Evista) –
Z79.810 - selective estrogen receptor modulators (SERMs) –
Z79.810 - sirolimus –
Z79.623 - steroids
- tacrolimus –
Z79.621 - tamoxifen (Nolvadex) –
Z79.810 - tofacitinib –
Z79.622 - topoisomerase inhibitor –
Z79.634 - topotecan –
Z79.634 - toremifene (Fareston) –
Z79.810 - vinblastine –
Z79.633 - vincristine –
Z79.633
How to choose the right code
Start with the main term, then pick the indented subterm that matches the documentation (type, cause, site, laterality, episode of care). Always confirm the code in the tabular list: follow its Excludes1/Excludes2, “code first” and “use additional code” notes, and add a 7th character where required.
Source: CDC/NCHS ICD-10-CM FY2027 alphabetic index.